Tag Archives: LPAD

Refilling the Antibiotic Pipeline: How to Lead the Horse to Water?

Last week, the United States Center for Disease Control (CDC) and Britain’s Chief Medical Officer issued separate warnings about the urgent problem of antibiotic resistance in infectious diseases. Given industry’s general lack of interest in developing new antibiotics to address this problem, the warnings indicate that a discussion is needed around which incentives and regulatory […]
Posted in FDA, Global, Market Access, pricing, R&D, Regulatory, Safety, Strategy | Also tagged , , , | 1 Comment
  • Categories

  • Meta